New Global Patient Alliance Is Raising Profile of Chronic Kidney Disease
A new global coalition, the Global Patient Alliance for Kidney Health, launched last week. With 17 member organizations spanning five continents, the Alliance hopes to improve screening access and early treatment for a serious but often neglected public health challenge: chronic kidney disease, or CKD.
New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda
Seventeen patient advocacy organizations from North and South America, Europe, Asia and the Middle East have formed the Global Patient Alliance for Kidney Health. The Alliance aims to elevate patient voices and advocate for policies that enhance access to screening and early treatment of chronic kidney disease, or CKD.
Calculating Cardiovascular Risk in Australia
One in every four deaths in Australia stems from cardiovascular disease, according to 2021 data. And more than 1 million Australians live with heart disease, stroke or vascular conditions.
Traitement de l’hypertension artérielle: les nouvelles directives européennes ouvrent la voie à un meilleur accès à la procédure
La European Alliance for Patient Access se félicite de l’ajout de la dénervation rénale à la liste des traitements approuvés pour l’hypertension artérielle
Neue europäische Hypertonie-Leitlinien ebnen den Weg für einen verbesserten Zugang zu Bluthochdruckverfahren
European Alliance for Patient Access begrüßt die Aufnahme der renalen Denervierung in die Liste der empfohlenen Behandlungen für arteriellen Bluthochdruck
Las nuevas directrices europeas sobre hipertensión allanan el camino para un mayor acceso al procedimiento de hipertensión arterial
La Alianza Europea para el Acceso de Pacientes recomienda que se agregue la denervación renal a la lista de tratamientos aprobados para la hipertensión arterial
New European Hypertension Guidelines Pave the Way for Greater Access to High Blood Pressure Procedure
European Alliance for Patient Access commends renal denervation being added to list of endorsed treatments for arterial hypertension.
Novo Projeto de Lei Mostra Promessa para Ensaios Clínicos no Brasil
Com a participação girando em torno de 2%, os ensaios clínicos no Brasil enfrentam desafios reais. Por isso, públicos interessados estão se unindo para entender o motivo disso – e encontrar soluções políticas.
New Policy Shows Promise for Clinical Trials in Brazil
With participation hovering at a meager 2%, clinical trials in Brazil face real challenges. Now stakeholders are coming together to understand why – and to find policy solutions.
In Europe Preserving Patient Choice Amongst COVID-19 Vaccines
COVID-19 vaccines have made it possible for most Europeans to resume daily routines, gather with friends and family, and return to school and the workplace. Recent news reports, however, have raised concerns that patients in the EU may soon lack options amongst different vaccines.
